RLYB Rallybio Corp
Price (delayed)
$1.1
Market cap
$45.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.78
Enterprise value
$29.25M
Highlights
RLYB's debt is down by 41% year-on-year and by 16% since the previous quarter
The EPS is up by 8% year-on-year and by 4.8% since the previous quarter
Rallybio's net income has decreased by 4.8% YoY but it has increased by 3.1% QoQ
The quick ratio has plunged by 57% YoY and by 22% from the previous quarter
The equity has declined by 43% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of RLYB
Market
Valuations
Earnings
Shares outstanding
41.49M
Market cap
$45.64M
Enterprise value
$29.25M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.57
Price to sales (P/S)
162.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
97.82
Revenue
$299,000
EBIT
-$73.88M
EBITDA
-$73.74M
Free cash flow
-$54M
Per share
Balance sheet
Liquidity
EPS
-$1.78
Free cash flow per share
-$1.22
Book value per share
$1.93
Revenue per share
$0.01
TBVPS
$2.09
Total assets
$92.43M
Total liabilities
$12.41M
Debt
$284,000
Equity
$80.02M
Working capital
$79.28M
Debt to equity
0
Current ratio
7.52
Quick ratio
7.29
Net debt/EBITDA
0.22
Margins
Efficiency
Dividend
EBITDA margin
-24,661.9%
Gross margin
100%
Net margin
-24,709.4%
Operating margin
-25,851.8%
Return on assets
-67.1%
Return on equity
-74.1%
Return on invested capital
-91.9%
Return on capital employed
-92%
Return on sales
-24,709.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RLYB stock price
How has the Rallybio stock price performed over time
Intraday
0%
1 week
-0.9%
1 month
0%
1 year
-77.69%
YTD
-53.97%
QTD
-17.91%
Financial performance
How have Rallybio's revenue and profit performed over time
Revenue
$299,000
Gross profit
$299,000
Operating income
-$77.3M
Net income
-$73.88M
Gross margin
100%
Net margin
-24,709.4%
Rallybio's net income has decreased by 4.8% YoY but it has increased by 3.1% QoQ
RLYB's operating income is down by 3.9% year-on-year but it is up by 3.8% since the previous quarter
Growth
What is Rallybio's growth rate over time
Valuation
What is Rallybio stock price valuation
P/E
N/A
P/B
0.57
P/S
162.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
97.82
The EPS is up by 8% year-on-year and by 4.8% since the previous quarter
The equity has declined by 43% year-on-year and by 10% since the previous quarter
RLYB's price to book (P/B) is 29% lower than its last 4 quarters average of 0.8
Efficiency
How efficient is Rallybio business performance
RLYB's return on equity has dropped by 56% year-on-year and by 11% since the previous quarter
Rallybio's return on assets has shrunk by 51% YoY and by 9% QoQ
The ROIC has declined by 36% year-on-year and by 10% since the previous quarter
Dividends
What is RLYB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RLYB.
Financial health
How did Rallybio financials performed over time
The current ratio has dropped by 59% year-on-year and by 23% since the previous quarter
The quick ratio has plunged by 57% YoY and by 22% from the previous quarter
RLYB's debt is 100% smaller than its equity
The equity has declined by 43% year-on-year and by 10% since the previous quarter
RLYB's debt is down by 41% year-on-year and by 16% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.